Literature DB >> 16966282

Bortezomib is effective in primary plasma cell leukemia.

Damian P J Finnegan, Paul Kettle, Mary Drake, Christine Matthews, H Denis Alexander, Rakesh Popat, Jamie D Cavanagh, William Wachsman, T C M Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16966282     DOI： 10.1080/10428190500520954

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

1.  Primary plasma cell leukemia followed by testicular plasmacytoma.

Authors:  Caterina Giovanna Valentini; Valentina Bozzoli; Luana Fianchi; Maria Teresa Voso; Gianluigi Di Paolantonio; Marianna Criscuolo; Giuseppe Leone; Luigi Maria Larocca; Livio Pagano
Journal:  Int J Hematol       Date:  2011-01-13       Impact factor: 2.490

2.  Primary plasma cell leukemia and autologous stem cell transplantation.

Authors:  Mary B Drake; Simona Iacobelli; Anja van Biezen; Curly Morris; Jane F Apperley; Dietger Niederwieser; Bo Björkstrand; Gösta Gahrton
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

Review 3.  Plasma cell leukaemia and other aggressive plasma cell malignancies.

Authors:  Taimur Sher; Kena C Miller; George Deeb; Kelvin Lee; Asher Chanan-Khan
Journal:  Br J Haematol       Date:  2010-08       Impact factor: 6.998

Review 4.  Plasma cell leukemia.

Authors:  Flavio Albarracin; Rafael Fonseca
Journal:  Blood Rev       Date:  2011-02-03       Impact factor: 8.250

Review 5.  Primary Plasma Cell Leukemia: Identity Card 2016.

Authors:  Pellegrino Musto; Vittorio Simeon; Katia Todoerti; Antonino Neri
Journal:  Curr Treat Options Oncol       Date:  2016-04

6.  Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia.

Authors:  Tommasina Guglielmelli; Roberta Merlini; Emilia Giugliano; Giuseppe Saglio
Journal:  J Oncol       Date:  2009       Impact factor: 4.375
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.